HER2-targeting antibody-drug conjugate RC48 alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study
HER2靶向抗体药物偶联物RC48单药或联合免疫疗法治疗局部晚期或转移性尿路上皮癌:一项多中心真实世界研究
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-023-03419-1
Chen, Meiting; Yao, Kai; Cao, Manming; Liu, Hao; Xue, Cong; Qin, Tao; Meng, Lingru; Zheng, Zhousan; Qin, Zike; Zhou, Fangjian; Liu, Zhuowei; Shi, Yanxia; An, Xin